Malaysia joins the collaborative registration procedure
M
Hetero’s dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Lupin’s lamivudine/tenofovir 300mg/300mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Teva’s generic atazanavir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First co-blister of daclatasvir/sofosbuvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Cipla’s 30mg and 60mg daclatasvir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Hetero’s daclatasvir 30mg and 60mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Roche sulfamethoxazole/trimethoprim prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Celltrion’s lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: